Region:
India
Category:
Society

India releases hydroxychloroquine stocks amid pressure from Trump

  • India releases hydroxychloroquine stocks amid pressure from Trump
    Dr Anthony Fauci has repeatedly warned that there is no conclusive evidence to support using the drug. Asked whether it should be considered a treatment for Covid-19, he said on 24 March: “The answer is no.” India releases hydroxychloroquine stocks amid pressure from Trump
Region:
India
Category:
Society
Publication date:
Print article

US president called Modi and threatened ‘retaliation’ if country kept full export ban

India has approved some exports of hydroxychloroquine, an anti-malaria drug being touted as a possible coronavirus treatment, after apparent pressure from Donald Trump, who has been urging Americans to take it.

The tablets are used to prevent and treat malaria, lupus and rheumatoid arthritis but over the past week the US president has been aggressively promoting the drug as a treatment for coronavirus, despite there being no conclusive medical evidence to prove its efficacy.

India, the world’s largest producer of hydroxychloroquine, had put a temporary export ban on the drug in order to preserve domestic stocks.

But in a statement on Tuesday morning, Anurag Srivastava, a government spokesperson, said that India had lifted some restrictions after officials had “confirmed the availability of medicines for all possible contingencies currently envisaged”.

Srivastava added that hydroxychloroquine would be kept in a “licensed” category, with the demand “continuously monitored”.

The partial lifting of the export ban comes after Trump confirmed he had called Narendra Modi, the Indian prime minister, over the weekend threatening “retaliation” if the country did not release its stocks.

Trump and Modi have a close relationship. On his inaugural visit to India in February, Trump declared Modi an “exceptional leader” and “true friend”.

During a press briefing at the White House on Monday, Trump said: “I spoke to him [Modi] Sunday morning, called him, and I said we’d appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be OK, but of course, there may be retaliation. Why wouldn’t there be?”

In recent days, Trump has developed a public obsession with hydroxychloroquine as a miracle cure for coronavirus, boasting that the US had already stockpiled 29m doses of the drug. The basis for the president’s proclamations of the drug as a “game changer” is a study carried out by a group of scientists in March, but the results have been openly dismissed by experts and major medical bodies.

Donald Trump used his daily White House coronavirus briefings to again urge Americans to take hydroxychloroquine, an anti-malaria drug that has not been shown to be safe or effective against Covid-19.

“What do you have to lose? Take it,” the president said on Saturday as he boasted that the US had amassed 29m doses of the drug. On Sunday, facing questions from the press about his aggressive promotion of an unproven treatment, he argued against waiting for the completion of clinical trials. “In France, they had a very good test,” he said. “But we don’t have time to go and say, ‘Gee, let’s take a couple of years and test it out, and let’s go and test with the test tubes and the laboratories.’”

Meanwhile, Dr Anthony Fauci, the country’s top infectious disease doctor, has repeatedly warned that there is no conclusive evidence to support using the drug. Asked whether it should be considered a treatment for Covid-19, he said on 24 March: “The answer is no.”